Error
Jump to navigation
Jump to search
There is currently no text in this page. You can search for this page title in other pages, search the related logs, or create this page.
Pages in category "News"
The following 184 pages are in this category, out of 184 total.
D
G
- Genetic risk of atrial fibrillation. July 12, 2007
- Genetic variability is linked to differences in response to warfarin therapy
- Glycemic index diets: More lentils, less mushy white bread. July 19, 2007
- Gradual decline in mortality rate following STEMI in the United States
- Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI
H
- HDB Tirofiban decreases rate of periprocedural myocardial infarction compared to placebo in patients with poor responsiveness to clopidogrel and aspirin: Results of the 3T/2R study
- Heart failure: A1 Adenosine Antagonists for Heart Failure
- Heart Failure: Acoustic Cardiography Improves Clinicians’ Confidence for Making the Diagnosis when BNP is Ambiguous
- Heart Failure: Data wanted on Effective Management Strategies for Patients with HF and PSF
- Heart Failure: Increasing Role of Advanced Practice Nurses in Heart Failure Management
- Heart Failure: Results of CORONA trial released
- Heart muscle cells grown from human embryonic stem cells can help repair damaged hearts following a heart attack. August 30, 2007
- High Dose Diuretics Associated with Adverse Outcomes in ADHERE
- High dose tirofiban and clopidogrel are safe and effective in the ON-TIME-2 trial
- High Dose Tirofiban is similar to Abciximab in reducing Major Adverse Cardiac Events
- High dose Tirofiban Might be Beneficial among Poor Responders to Clopidogrel and Aspirin Following Elective PCI: Results of the 3T/2R study
- High recurrence rate of stent thrombosis after the first event: Results from the Dutch Stent Thrombosis Registry
- High red cell distribution width associated with adverse outcomes in patients with coronary artery disease
- Homocysteine lowering with B vitamins again fails to show benefit
- Hospital-level Mortality Data for MI, CHF Available on Federal Website. June 25, 2007
- How do I submit news article
- Hoy en Medicina: El estudio SALT cuestiona la prevalencia de hiperaldosteronismo primario no diagnosticado en pacientes con hipertension y bajos niveles de renina
I
- Immediate transfer for PCI after fibrinolysis plus abciximab improves outcome in CARESS-in-AMI trial
- Implantation of skeletal myoblasts into scarred myocardium improves symptoms but not heart function
- In vivo imaging of inflammatory cells trafficking to atherosclerotic lesions
- Increased white blood cell count and ventricular remodeling
- Inflammatory biomarkers predict short-term mortality in patients with peripheral arterial disease
- Inhaled anticholinergics for the treatment of COPD is associated with an increased risk of cardiovascular events.
- Insertable Loop Recorder Tracks Cardiac Arrhythmias Following Acute Myocardial Infarction
- Intensified NT BNPguided Therapy might be Beneficial among Patients aged less than 75 Years: Results from the TIME-CHF Trial
- Intensive blood sugar control among diabetics does not increase mortality in the ADVANCE trial
- Intensive blood sugar control is associated with increased mortality among type 2 diabetics in ACCORD
- Intracoronary abciximab is superior to intravenous infusion in reducing infarct size during primary PCI
- Intracoronary infusion of selected and unselected mononuclear cells does not lead to significant improvement in cardiac function after sustained ischemia: Results from the REGENT trial
- Intravenous iron for treatment of anemia in heart failure
- It’s About Time: A Regionalized Approach to Patients with AMI. August 8, 2007
J
L
- Lancet Editor Forsees Wikis as the Future for Medical Journals
- Landmark analysis of the TRITON-TIMI 38 trial demonstrates significant benefit with the loading and maintenance doses of prasugrel
- Larger Versus Smaller Clinical Safety Databases for Regulatory Approval of Drugs.
- LDL Cholesterol and its Association with Cancer: July 24, 2007
- Left main coronary artery disease: which stent type is preferred for off-label PCI?
- Left main stenting is associated with similar rates of death, Q wave myocardial infarction and stroke compared with CABG at 3-year follow-up
- Long Term Adherence to Clopidogrel and Late Adverse Cardiac Events after Off-Label Use of Sirolimus-Eluting Stents: Results of the MATRIX Registry
- Long-term outcomes of off-pump vs. on-pump coronary artery bypass grafts. August 12, 2007
- Loss of adenylyl cyclase gene increases life span and protects the aging heart. August 10th, 2007
- Low-risk Women with Unstable Angina and NSTEMI Might be Better off with Medical Therapy than Invasive Treatment
- LV Remodeling Reversed among Patients with Asymptomatic Systolic Dysfunction with Metoprolol
M
- Making the most of cardiac resynchronization therapy : remotely monitoring patients
- MC-1 does not reduce cardiovascular and cerebrovascular events in phase 3 MEND-CABG II trial
- MC-1 does not reduce cardiovascular and cerebrovascular events in the phase 3 MEND-CABG II trial
- Measuring Fractional Flow Reserve During PCI Improves 1-Year Outcomes
- MEND-CABG II trial does not suggest improved outcomes with the novel drug MC1 in patients undergoing high risk coronary artery bypass surgery
- Metabolic syndrome linked to higher rates of atrial fibrillation
- Metabolic syndrome: Study links soft drink consumption with increased risk of developing metabolic syndrome
- Metoprolol Associated with Lower Rates of Major CV Events in POISE Trial for High Risk Patients Undergoing Noncardiac Surgery
- Microvolt T Wave Alternans Test (MTWA) not Predictive of Ventricular Arrhythias Following MI
- More evidence of the primacy of chest compressions over ventilation in cardiopulmonary resuscitation
- Myeloperoxidase levels shown to predict future cardiovascular risk in healthy individuals. July 11, 2007
N
- Nephrotic syndrome and risk of venous and arterial thromboembolism
- New AHA statement focuses on improving rates and success of bystander CPR
- New AHA statement on hyperglycemia during ACS admissions
- New formula for predicting long-term survival based on exercise treadmill testing
- New guidelines for the management of cocaine chest pain
- New guidelines hope to clarify the role of endomyocardial biopsies
- New meta-analysis demonstrates significant incidence of psychiatric side effects of the weight loss medication rimonabant
- New practice guidelines for use of biomarkers in ACS and heart failure. July 22, 2007
- New randomized comparison of unprotected left main coronary artery stenting and CABG
- New study uses gene variants to predict cardiovascular risk
- New target for treating salt-induced hypertension
- News:NT-proBNP Guided vs. Sympton-Guided Heart Failure Therapy
- NHLBI recommends early termination of the intensive blood sugar lowering strategy in the ACCORD trial
- NOBORI™ stent is non-inferior to Taxus® stents in the NOBORI 1 trial
O
P
- Paclitaxel coated angioplasty balloons are effective in reducing restenosis in the leg
- Paclitaxel eluting stents are safe and effective in diabetic patients compared to bare metal stents
- Panic Attacks in Postmenopausal Women Increase Risk of CV Events
- PCI: Nonclinical factors may influence physician decision-making
- PEPCAD II ISR study suggests that drug eluting balloons are safe and effective compared with drug eluting stents in treating in-stent restenosis
- Percutaneous Coronary Interventions can be performed in centers without on-site cardiac surgical back-up
- Periostin: A possible treatment for heart failure. July 20, 2007
- Pioglitazone Prevents Progression of Coronary Atherosclerosis in Diabetic Patients With Coronary Artery Disease: Results of the PERISCOPE Trial
- Planning your New Year’s resolution—which diet is best?
- Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients
- Pre Treatment with 600 mg of Clopidogrel does not Improve Outcomes in Stable PCI Patients: PRAGUE-8
- Pre-operative Statin Therapy Improves Clinical Outcomes among Cardiac Surgical Patients: Results from a Meta-Analysis
- Predicting the Mode of Death for Heart Failure Patients. July 29, 2007
- Predicting who will benefit from cardiac resynchronization therapy: results of PROSPECT
- Preoperative statins for prevention of atrial fibrillation following cardiac surgery
- Prevention: Results of the ILLUMINATE Trial Released at AHA 2007
- PRoFESS®, the Largest Recurrent Stroke Prevention Trial Results were Presented at the 17th European Stroke Conference
- Promising results from a phase 2 study of a vaccine for hypertension
- PROVIDENCE-1 trial Results: Rifalazil Has No Effect in Patients with Intermittent Claudication
- Pulmonary embolism is the cause of approximately 10% of hospital deaths despite approved therapies for treatment and prevention. July 26, 2007
R
- Recombinant Human Erythropoietin (rHuEpo): Lack of Effect on Response to ASA or Clopidogrel
- Reductive stress, like its counterpart oxidative stress, can induce cardiomyopathy. August 16th, 2007
- Reloading With Clopidogrel Improves Clinical Outcomes in Patients with Acute Coronary Syndromes: ARMYDA-RELOAD
- Remote ischemic preconditioning may improve clinical outcomes after CABG procedure
- Removal of debris from the coronary arteries does not improve outcomes: Results from the A-F study
- Renin: who needs it, anyway?
- Results from STITCH Trial Demonstrate a Simplified, Step-Care Process is More Effective than Guidelines-Based Practice in Hypertension Treatment
- Rethinking a “healthy weight”: New study finds that being overweight is not associated with increased mortality from cardiovascular causes
- Revascularization with CABG or PCI had no Difference on Outcomes of Death, non-fatal MI, or CVA for Diabetics with Multi-Vessel Coronary Disease: Results of the CARDia Trial
- Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality
- Rhythm control is no better than rate control among patients with atrial fibrillation and congestive heart failure
- Rimonabant does not reduce atherosclerosis progression in STRADIVARIUS
- RNAPc2 in ACS, Results of ANTHEM-TIMI 32. June 22, 2007
- Rosiglitazone: Twists and Turns on the Road to Clarity Regarding Safety with Rosiglitazone. August 10, 2007
- Rosuvastatin is Not Beneficial Among Patients with Chronic Heart Failure: Results from GISSI-HF trial
- Rosuvastatin reduces coronary artery disease progression over time in the ASTEROID trial
S
- Should beta-Blockers Be Continued for Patients Hospitalized with decompenstated Heart Failure
- Similar nephrotoxic effects with iodixanol and iomeprol in the CONTRAST trial
- Simvastatin and ezetimibe combination does not reduce the rate of progression of aortic valve disease in the SEAS trial
- SPECT Substudy of COURAGE shows Improved Perfusion with PCI at Follow-Up
- Standard Physician Care for Heart Failure is Just as Effective as and Less Expensive Than a Home Monitoring System
- States and Institutions Impose Restrictions on Physician-Industry Relationships
- Statins found to be protective against recurrence of atrial fibrillation after cardioversion
- Statins in Heart Failure: Results of CORONA
- Statins may cause sleep disorders
- Stents: Johnson & Johnson Reports Significant Decrease in Stent Sales
- News:Study demonstrates that non-cardiac cells can help repair a damaged heart; new excitement for existence of cardiac stem cells. August 26, 2007
- Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Study proposes a final common pathway linking smoking, kidney disease, and inflammation to atherogenesis
- Subendocardial Ischemia In Patients with Chest Pain and Normal Coronary Angiograms: A Cardiovascular Magnetic Resonance Study
- Successful PCI for Chronic Total Occlusion of the LAD is Associated with Improved Long-term Survival
- Sunitinib, a small molecular weight tyrosine-kinase inhibitor, is found to have cardiac toxicity
- Susceptibility loci for intracranial aneurysm in European and Japanese populations
- SYNTAX study fails to support PCI as non-inferior to CABG in patients with left main or 3-vessel coronary artery disease
T
- Telmisartan is as effective and safe as ramipril in patients at high risk for vascular events: Results from the ONTARGET trial
- The 2009 SCAI Annual Scientific Sessions is to be held in Las Vegas
- The ASTRAL Trial Demonstrates Angioplasty and Stenting Offer No Benefit Over Medical Therapy in Patients with Renal Arterial Stenoses
- The Couma-Gen Study did not Demonstrate a Reduction in Out-of-range INRs in Patients with Pharmacogenetic-guided Dosing of Warfarin
- The Efficacy of XIENCE V Stent over Taxus Stent Decreases with Time: Results from the SPIRIT II study
- The EVEREST trial suggests MitraClip® for mitral regurgitation is effective
- The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
- The GISSI-HF trial suggests long-term treatment with n-3 PUFAs provides moderate clinical benefits for chronic heart failure patients
- The On-Time 2 trial Suggests Benefit with Early Administration of Tirofiban in the Ambulance following Acute Myocardial Infarction.
- The safety of thiazolidinediones in older diabetics
- Thrombus aspiration in patients with ST elevation myocardial infarction improves mortality at 1 year in the TAPAS trial
- News:Thyroid abnormalities affect more than 30% of males on amiodarone
- Ticagrelor is superior to Clopidogrel in the treatment of patients with acute coronary syndrome with or without ST-segment elevation: Results of the PLATO study
- Time to Abandon Facilitated PCI: Results from the FINESSE trial
- Tirofiban and transfer compares favorably to fibrinolysis in STEMI
- Today In Medicine: European Heart Journal Announces Articles to be Available in Open Source Format
- Today in Medicine: Implanting the Same vs. Different Drug-Eluting Stent (DES) for the Treatment of DES Restenosis.
- Today in Medicine: Judges or Defendants: Should the Journals be the Judges on Conflict of Interest?
- Today in Medicine: Mixed Long-term Results for Sirolimus-Eluting Stent Implantation in Diabetic Patients
- Today in Medicine: NY Times Describes Health and Economic Impact of Ablation for A Fib
- Today in Medicine: SALT study questions prevalence of undiagnosed primary hyperaldosteronism among patients with low-renin hypertension
- Today in Medicine: Study Examines Use of CD34+ Stem Cells in Advanced CAD Patients
- Today in Medicine: Study Shows Favorable Long-Term Outcomes for DES Implantation in Unprotected Left-main Lesions
- Torcetrapib Associated with Higher CV Event Rates in ILLUMINATE
- TRANSCEND Study Misses Primary Endpoint
- TRANSCEND Study suggests that telmisartan reduces cardiovascular events
- Transfusion of blood stored for more than 14 days increases mortality among cardiac surgical patients
- Treatment of hypertension in the very old reduces all-cause mortality
- Treatment of hypertension with indapamide with or without perindopril is beneficial in the elderly: Results from the HYVET study
- Treatment of paroxysmal nocturnal hemoglobinuria with the anti-complement antibody eculizumab helps prevent thromboembolism
- TRITON-TIMI 38 stent analysis demonstrates that prasugrel is better than clopidogrel in reducing the incidence of early and late stent thrombosis
U
- Understanding the stiff heart: scientists discover the cells and molecules responsible for cardiac fibrosis. August 12, 2007
- Underutilization of Cardiac Rehab Despite Guidelines and Reimbursement
- Upstream Pharmacotherapy not Superior to Cath Lab Based Therapy in Primary PCI: Results from the FINESSE Trial
- Use of Epoetin Alpha in Critically Ill Patients. Sept 10th, 2007.
- Use of Epoetin Alpha in Critically Ill Patients. Sept 8th, 2007.